🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesNNT for MACE prevention — what worked for you? Page 4

NNT for MACE prevention — what worked for you?

Dr.LipidDallas Wed, Jan 24, 2024 at 1:42 AM 16 replies 2,206 viewsPage 4 of 4
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Jan 26, 2024 at 9:24 PM#16

Clinical perspective, offered as context rather than as advice.

Mendelian randomization evidence supporting GLP-1 pathway modulation for cardiovascular risk: genetic variants in the GLP1R gene region associated with lower BMI also show associations with reduced cardiovascular risk, confirming a causal pathway[1].

This "natural experiment" (people born with genetically higher GLP-1 signaling being leaner and healthier) provides orthogonal evidence supporting the pharmacological approach. When genetic epidemiology, clinical trials, and mechanistic studies all converge, confidence in the therapeutic approach is high.

References:
[1] Zheng SL, et al. Lancet Diabetes Endocrinol. 2023;11(12):869-879.
Last edited: Jan 27, 2024 at 3:24 AM
29 2Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 26 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Jan 27, 2024 at 7:23 AM#17
labquiet_amy said:
Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling,…

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

30 3traveltech_sara, AttorneyGrant, DebRD_ATL and 27 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Jan 27, 2024 at 5:22 PM#18
labquiet_amy said:
Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling,…

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off lisinopril entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

31 4KevinCompounds, TirzTom, TrialTracker_MD and 28 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Jan 28, 2024 at 3:21 AM#19

One thing that is still open after labquiet_amy’s answer:

How long did you give it before you decided it was working?

32 5PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 29 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jan 28, 2024 at 1:20 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

Last edited: Jan 28, 2024 at 3:20 PM
4 2PurityPaulOR, MaxMetOK, MounjBrad and 1 other
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register